about
Use of the Theoretical Domains Framework to evaluate factors driving successful implementation of the Accelerated Chest pain Risk Evaluation (ACRE) project.Ventricular tachyarrhythmia during pregnancy in women with heart disease: Data from the ROPAC, a registry from the European Society of Cardiology.Comprehensive standardized data definitions for acute coronary syndrome research in emergency departments in Australasia.A 2-h diagnostic protocol to assess patients with chest pain symptoms in the Asia-Pacific region (ASPECT): a prospective observational validation study.Cardiac implications for the use of beta2-adrenoceptor agonists for the management of muscle wasting.Relationship Between Physiological Parameters and Acute Coronary Syndrome in Patients Presenting to the Emergency Department With Undifferentiated Chest Pain.Fundamental considerations of beta-adrenoceptor subtypes in human heart failure.Change to costs and lengths of stay in the emergency department and the Brisbane protocol: an observational study.Human heart beta-adrenoceptors: beta1-adrenoceptor diversification through 'affinity states' and polymorphism.Valvular and aortic diseases in osteogenesis imperfecta.Non-physician-led exercise stress testing is a safe and effective practice.Limited utility of exercise stress testing in the evaluation of suspected acute coronary syndrome in patients aged less than 40 years with intermediate risk features.Assessment of the 2016 National Institute for Health and Care Excellence high-sensitivity troponin rule-out strategy.Characteristics and occurrence of type 2 myocardial infarction in emergency department patients: a prospective study.The organisational value of diagnostic strategies using high-sensitivity troponin for patients with possible acute coronary syndromes: a trial-based cost-effectiveness analysis.Rational clinical evaluation of suspected acute coronary syndromes: The value of more information.Rapid Rule-out of Acute Myocardial Infarction With a Single High-Sensitivity Cardiac Troponin T Measurement Below the Limit of Detection: A Collaborative Meta-analysis.Validating the Manchester Acute Coronary Syndromes (MACS) and Troponin-only Manchester Acute Coronary Syndromes (T-MACS) rules for the prediction of acute myocardial infarction in patients presenting to the emergency department with chest pain.Differences in Presentation, Management and Outcomes in Women and Men Presenting to an Emergency Department With Possible Cardiac Chest Pain.Panic Disorder in Patients Presenting to the Emergency Department with Chest Pain: Prevalence and Presenting Symptoms.Factors influencing choice of pre-hospital transportation of patients with potential acute coronary syndrome: An observational study.Utility of Routine Exercise Stress Testing among Intermediate Risk Chest Pain Patients Attending an Emergency Department.The Association of Electrocardiographic Abnormalities and Acute Coronary Syndrome in Emergency Patients With Chest Pain.Agreement Between Patient-reported and Cardiology-adjudicated Medical History in Patients With Possible Ischemic Chest Pain: An Observational Study.Diagnosis of Myocardial Infarction Using a High-Sensitivity Troponin I 1-Hour Algorithm.Global cardiac risk assessment in the Registry Of Pregnancy And Cardiac disease: results of a registry from the European Society of Cardiology.Validation of presentation and 3 h high-sensitivity troponin to rule-in and rule-out acute myocardial infarction.Time to presentation and 12-month health outcomes in patients presenting to the emergency department with symptoms of possible acute coronary syndrome.Sex-specific versus overall cut points for a high sensitivity troponin I assay in predicting 1-year outcomes in emergency patients presenting with chest pain.A Clinical Decision Rule to Identify Emergency Department Patients at Low Risk for Acute Coronary Syndrome Who Do Not Need Objective Coronary Artery Disease Testing: The No Objective Testing Rule.Two-Hour Algorithm for Triage toward Rule-Out and Rule-In of Acute Myocardial Infarction by Use of High-Sensitivity Cardiac Troponin I.Cost and outcomes of assessing patients with chest pain in an Australian emergency department.Combining presentation high-sensitivity cardiac troponin I and glucose measurements to rule-out an acute myocardial infarction in patients presenting to emergency department with chest pain.Delta troponin for the early diagnosis of AMI in emergency patients with chest pain.A probable right atrial myxoma prolapsing through the tricuspid valve into the right ventricle: a case report.An examination of clinical intuition in risk assessment among acute coronary syndromes patients: observations from a prospective multi-center international observational registry.More biomarkers for risk stratification of chest pain: bigger, faster, better?Performance of risk stratification for acute coronary syndrome with two-hour sensitive troponin assay results.Use of observed within-person variation of cardiac troponin in emergency department patients for determination of biological variation and percentage and absolute reference change values.The new Vancouver Chest Pain Rule using troponin as the only biomarker: an external validation study.
P50
Q30821844-59310976-4156-4A45-8A20-EC07797290E2Q31112288-A9FB438F-85A7-4E95-8BCF-7D607573C044Q33529840-A1CF517A-E430-4BB6-838E-DCEFECD879B2Q33855133-F79F61AB-9761-4BB0-916E-202381B3E486Q35545370-925E942A-5204-47D5-B722-E704FBBF3AB5Q35556573-E32B7A7E-E7EB-435B-A3F6-6FC033720335Q36152360-E0FD9598-09AE-4AB7-861F-9F723E2B9EF3Q36625329-8597C43F-9728-455F-9C4C-454F409D6011Q36916953-D68682D9-A2A2-4632-BC7D-223734E0A9FAQ38116254-096A5954-33B9-49C2-8E7D-A8B907FB6E9AQ38163317-5C59B036-F8A7-490C-AA56-80DE07DBD44EQ38202677-F00D0ABE-3BDE-464F-8389-14ED1E8A7318Q38597180-C20DEC42-5B02-496C-B968-3289C0CFBEA7Q38636283-2E61C0F5-78B2-49F6-96D2-47108AD5C83BQ38732124-38F85ECA-4AF1-4A40-AFD5-968AD1AAEB6DQ38749095-61AE2E04-83D1-404C-A3DE-6E27B7E5CE6CQ38832719-3725AF23-284C-4745-BFFC-2F9584B81827Q38863851-7ECE8978-1A64-490A-AC75-9EAA80F22BA2Q38927886-51B38571-1160-41BA-8045-3139313D4113Q38931430-2C4AEF94-B77C-4D7C-8835-139D966A1403Q38999335-C171972A-8C02-4384-A873-8E6F2F281641Q39004736-6954CE07-FC9B-4A26-BB5F-F97508DA5887Q39232710-609ABFBF-DD17-4DA3-A178-41B5E88983C5Q39553594-0F55D5C6-DEFE-48D2-86BF-D2E7F6E67D67Q39580710-88625E3D-950D-4068-9D61-80A6A0152554Q39896343-6C5D5908-8E35-4C8F-B67C-0CD3D09E160BQ39938287-09691A8C-1E6D-4E3F-9165-E80A76FCBE10Q40092936-3885B893-106D-4FE7-B70E-49ADF384692CQ40146915-DC327DBE-0140-4747-85FE-FD3ED053E311Q40546161-15FCD33E-E124-48E9-9925-7491032D511FQ40958365-657A8824-67FD-4B8B-B1F9-AFBEF4D34DFFQ40991897-E40C0773-D549-4629-88C8-FD1F049E273AQ41716594-DBCAD9AA-B14C-4853-8FFA-CA4372AF3B56Q41970139-709A4B71-BCE4-4493-9CA9-FE1DCE08EDB7Q42139748-A1F29BEA-4BA1-4934-B2A2-A5818E8AC357Q43754474-C33C4C03-07CB-47BE-BF5A-5DD257A8F8CBQ44882378-C3E9177B-4208-467C-81AA-889D4FA06ED0Q45101015-D4E46AC1-C97F-4D1F-B10C-E821F2E142FAQ45819383-BD774781-9299-4C38-896F-B10BBF116BF1Q45934373-AB768792-F25F-4C51-A126-51C00C6705D3
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
William A Parsonage
@fr
William A Parsonage
@nl
William A Parsonage
@sl
William A. Parsonage
@en
William A. Parsonage
@es
type
label
William A Parsonage
@fr
William A Parsonage
@nl
William A Parsonage
@sl
William A. Parsonage
@en
William A. Parsonage
@es
altLabel
Will Parsonage
@en
prefLabel
William A Parsonage
@fr
William A Parsonage
@nl
William A Parsonage
@sl
William A. Parsonage
@en
William A. Parsonage
@es
P106
P1153
6603274691
P21
P31
P496
0000-0002-0223-5378